Cognition Therapeutics (CGTX) EPS (Basic) Growth (1y) (2021 - 2026)
Cognition Therapeutics (CGTX) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | -16.29% |
| 10 | Cognition Therapeutics | 88.98 Mn | 88.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.42% |
| Mar 31, 2026 | 55.56% |
| Dec 31, 2025 | 30.47% |
| Sep 30, 2025 | 76.69% |
| Jun 30, 2025 | 42.44% |
| Mar 31, 2025 | 51.68% |
| Dec 31, 2024 | 46.56% |
| Sep 30, 2024 | 26.62% |
| Jun 30, 2024 | -147.12% |
| Mar 31, 2024 | -118.22% |
| Dec 31, 2023 | 2.13% |
| Sep 30, 2023 | -77.23% |
| Jun 30, 2023 | 37.31% |
| Mar 31, 2023 | -23.96% |
| Dec 31, 2022 | 77.20% |
| Sep 30, 2022 | 96.46% |
| Jun 30, 2022 | 89.86% |
| Mar 31, 2022 | -142.22% |
| Dec 31, 2021 | 73.62% |
| Sep 30, 2021 | -52.89% |